Abstract
Benign prostatic hyperplasia (BPH) can have a profound affect on a patient's quality of life and sexual function and is considered by patients to be one of the most important aspects affected by the disease. Different treatments can produce a variable response in terms of the patient's quality of life, including sexual activity and satisfaction. Varying rates of erectile dysfunction (ED) and retrograde ejaculation following surgery for BPH have been reported. In general, the incidence of these side-effects is less after minimally invasive therapies, such as interstitial laser coagulation and transurethral microwave therapy, but the data available are limited. The lowest rates of sexual dysfunction are reported with medical therapies. The 5α-reductase inhibitor, finasteride, can result in ED in 5–9% of patients and ejaculation disorders in 0.8–2.0%. With the exception of tamsulosin, α1 blockers are associated with a low rate of sexual dysfunction. No cases of ED have been reported with alfuzosin and abnormal ejaculation with terazosin or alfuzosin is negligible. Indeed, early research suggests a beneficial effect of α1 blockers on sexual function. In addition to information on the efficacy of a particular therapy, patients should be informed of side effects, in particular those relating to sexual function, in order that they can make informed treatment decisions.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schulman, C. Impact of treatment of BPH on sexuality. Prostate Cancer Prostatic Dis 4 (Suppl 1), S12–S16 (2001). https://doi.org/10.1038/sj.pcan.4500541
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.pcan.4500541
- Springer Nature Limited
Keywords
This article is cited by
-
Point-counter-point debate: the association between recombinant human bone morphogenetic protein utilization and complications in spine surgery
Current Reviews in Musculoskeletal Medicine (2014)
-
Association of lower urinary tract symptoms and erectile dysfunction: pathophysiological aspects and implications for clinical management
International Journal of Impotence Research (2011)
-
Measurement of benign prostatic hyperplasia treatment effects on male sexual function
International Journal of Impotence Research (2009)
-
Pharmacology of α1-adrenoceptor antagonists in the lower urinary tract and central nervous system
Nature Clinical Practice Urology (2007)
-
Terazosin in the Treatment of Premature Ejaculation: A Short-term Follow-up
International Urology and Nephrology (2005)